File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

박철민

Park, Cheol-Min
Synthetic and Medicinal Chemistry Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

N-Aryl-benzimidazolones as novel small molecule HSP90 inhibitors

Author(s)
Bruncko, MilanTahir, Stephen K.Song, XiaohongChen, JunDing, HongHuth, Jeffrey R.Jin, ShaJudge, Russell A.Madar, David J.Park, Chang H.Park, Cheol-MinPetros, Andrew M.Tse, ChristinRosenberg, Saul H.Elmore, Steven W.
Issued Date
2010-12
DOI
10.1016/j.bmcl.2010.10.010
URI
https://scholarworks.unist.ac.kr/handle/201301/8540
Fulltext
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=78449271034
Citation
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.20, no.24, pp.7503 - 7506
Abstract
We describe the development of a novel series of N-aryl-benzimidazolone HSP90 inhibitors (9) targeting the N-terminal ATP-ase site. SAR development was influenced by structure-based design based around X-ray structures of ligand bound HSP90 complexes. Lead compounds exhibited high binding affinities, ATP-ase inhibition and cellular client protein degradation.
Publisher
PERGAMON-ELSEVIER SCIENCE LTD
ISSN
0960-894X

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.